Skip to main content
1100 Industrial Road, Suite 1, San Carlos, CA. 94070

Now, we are currently enrolling patients in our INHERIT trial. Learn more.

Past Studies

ROS1 PDX Study

ROS1 PDX Study


ROS1

Fusion Positive Tumors for PDX Study


ROS1-fusions occur in several cancer types – non-small cell lung cancer, gastric cancer, ovarian cancer, glioblastoma, cholangiocarcinoma, melanoma, and others. In each of these cancers, ROS1-fusions account for a small sliver of the pie, accounting for approximately 1-2% of all diagnoses, resulting in a relatively rare yet critically important molecular subset of cancer. The Addario Lung Cancer Medical Institute (ALCMI) is focusing efforts on this under-studied molecular subset of cancer to understand what drives tumor formation, therapeutic response, and acquired therapeutic resistance. Therefore, in support of cancer patients whose tumors have ROS1-fusions, we are launching a global effort to study ROS1-fusions across all tumor types.

THIS STUDY IS NOW CLOSED TO ENROLLMENT. 

Contact Form


Thank you for your interest. This study is now closed to enrollment.

Our Impact

  • Total Clinical Trials
    Total Clinical Trials

    23

  • Trial Participants
    Trial Participants

    1,754

  • Publication Citations and Downloads
    Publication Citations and Downloads

    13,659

  • Partners and Sponsors
    Partners and Sponsors

    56

Addario Lung Cancer Medical Institute (ALCMI)
1100 Industrial Road, Suite 1, San Carlos, CA. 94070
MENU CLOSE